Republic Republic Republic
  • Log in
Open account
Oops! We couldn’t find any results...
Can’t find a deal? Try advanced search.
Is something missing? Add your suggestion here.
Primary market Live deals Trading Buy and sell Republic Note Own a piece of Republic's upside
Republic Ventures Opportunities for accredited investors
Republic Capital Multi-stage venture firm
Wallet Manage your digital assets Mobile app Available on iOS or Android Learning center Explore investor resources FAQ Get your questions answered
Capital fundraising Raise on Republic Tokenized assets Design, launch, manage tokenized assets Sharedrops Gift equity as a reward Founder Academy A complete guide to raising funds
Advisory Access veteran web3 advisors Infrastructure Stake your digital assets Tokenization Deploy your assets on-chain
Republic Capital In-house Venture Capital fund Broker dealer Regulated capital services
Republic Republic Republic
Oops! We couldn’t find any results...
Can’t find a deal? Try advanced search.
Is something missing? Add your suggestion here.
  • US

  • Log in
  • Open account
All investors
Primary market Live deals Trading Buy and sell
Republic Note Own a piece of Republic's upside
Accredited only
Republic Ventures Opportunities for accredited investors
Institutional
Republic Capital Multi-stage venture firm
More
Wallet Manage your digital assets Mobile app Available on iOS or Android Learning center Explore investor resources FAQ Get your questions answered
Growth capital solutions
Capital fundraising Raise on Republic Tokenized assets Design, launch, manage tokenized assets Sharedrops Gift equity as a reward Founder Academy A complete guide to raising funds
Web3 services
Advisory Access veteran web3 advisors Infrastructure Stake your digital assets
Tokenization Deploy your assets on-chain
Institutional services
Republic Capital In-house Venture Capital fund
Broker dealer Regulated capital services

SnapDNA isn't accepting new investments

SnapDNA’s deadline was April 28, 2021

Follow the company to stay updated on their progress, including future investment opportunities


Explore new investment opportunities:
View companies raising now
Campaign ended
Logo of SnapDNA

SnapDNA

Solving the global food safety challenge
B2B Biotechnology
Facebook Telegram Twitter LinkedIn
Featured image of SnapDNA
Fully Funded
$1,070,000
Raised
1,774
Investors
Successfully funded and closed on April 28, 2021.
Invest in SnapDNA

Open for investment

Investors in SnapDNA also invested in these companies. View more
Logo of  Metaintro

Metaintro

The Bloomberg of Labor Markets - AI-powered workforc...

Republic Funding Portal · Reg CF
Logo of Rentberry

Rentberry

Invest Pre-IPO in the AI Revolution Transforming $13...

Republic Funding Portal · Reg CF
Logo of The Sports Bra

The Sports Bra

The world's first sports bar fully dedicated to wome...

Republic Funding Portal · Reg CF
Logo of Code Blue

Code Blue

AI that calls for help when you can’t

Republic Funding Portal · Reg CF
Logo of Mintworks

Mintworks

$30T opportunity by 2030. We turn any asset into dig...

Republic Funding Portal · Reg CF
Logo of OpenRange Social

OpenRange Social

Social Platform for the 54M Hunters, Anglers and Out...

Republic Funding Portal · Reg CF
Logo of Yakuru Inc.

Yakuru Inc.

Precision supplements, biometrics, and AI performanc...

Republic Funding Portal · Reg CF
Logo of Lumida Wealth

Lumida Wealth

Lumida is Scaling. Invest in the AI Platform Disrupt...

Republic Funding Portal · Reg CF
Loading...
Pitch Updates 13 Reviews 274
Invest Invest in SnapDNA
Facebook Telegram Twitter LinkedIn
Closed on April 28, 2021. Information may not be up-to-date. Campaign closed on April 28, 2021. Information displayed may not be up-to-date.
Problem Solution Product Traction Customers Biz. model Market Competition Vision and strategy Funding Founders
About Team

Documents

Republic (OpenDeal Portal LLC, CRD #283874) is hosting this Reg CF securities offering by Bio-NEMS Corporation. View the official SEC filing and all updates:
Official SEC Logo Form C SEC.gov
Company documents
SnapDNA Crowd SAFE SnapDNA Form C.pdf
Loading

Hear from some of the 1,774 investors in SnapDNA


Show more

Highlights


$1M+ raised
Company has previously raised over $1M in capital
  • Reduces the time for food pathogen testing from 3 days to 20 minutes
  • Selected as the preferred food testing platform by the USDA-ARS
  • Paid pilots with PepsiCo and Nestle; the world’s largest food companies
  • Reduces outbreaks, lowers food costs and allows for fresher, safer food
  • Leading the change in the $10 Billion per year food pathogen test market
  • Projected ARR of $150M in 2 years
  • $3M raised to date

Problem


Too many food recalls

Food recalls for potentially deadly pathogens like Listeria, Salmonella, and E. coli are on the rise. The diagnostic tools for tracing these contaminations rely on outdated 100-year-old technology. Analysis takes 3-7 days in a specialized, off-site lab and cannot distinguish between a raging contamination and a single errant cell. It’s no wonder that it can take a food company months to find and verify the source of an outbreak. The longer it takes, the higher the financial risk. A single outbreak can cripple a large company and bankrupt smaller ones.

New technologies are needed to reduce the number and severity of outbreaks. Dozens of companies have tried. None have succeeded. Until SnapDNA.

Solution


SnapDNA: Faster, Safer, and Fresher

SnapDNA addresses the food industry’s most critical need: reducing the number and the severity of outbreaks, lowering production costs, and allowing fresher, safer food.

SnapDNA has the first self-contained, on-site analysis designed to replace all food pathogen lab tests. Results are available in 20 minutes and hundreds of samples can be analyzed per day. Unlike lab tests, SnapDNA provides quantitative data to reduce the time to find contaminations from months to days, enabling predictive analytics to help prevent outbreaks.

SnapDNA test results are available when product is ready to ship enabling fresher, safer food. Food companies save millions of dollars/year in storage costs and reduce exposure to contamination and recalls.

Product


The right answers, right now

SnapDNA’s customer proven system reduces the time for a pathogen test from 3-7 days to 20 minutes. It works with any size sample, from a tablespoon to a few liters. Analysis is performed in self-contained, single-use cartridges; each acting as a miniature, computer-controlled laboratory. It can be operated almost anywhere, by almost anyone.

SnapDNA can be used where food is produced, packaged, or grown. It is as accurate as a lab test and much less susceptible to human error. Test results are uploaded to the cloud so food safety professionals can monitor all of their facilities in real-time and identify potential contamination events before product is shipped.

Our technology...

Your browser does not support HTML5 video.

Traction


Tipping point technology

We have key strategic corporate partnerships...

 

“SnapDNA can save us dollars in an industry that measures margin in pennies. If anyone in my market adopts SnapDNA, we’ll all have to adopt to stay competitive”. – CEO of a protein company

“SnapDNA is a no-brainer. We spend $2M a year on pathogen tests and $3M on cold storage waiting 3 days for lab results”.
– VP Food Safety for a mid-size snack food company

...and government partnerships

The USDA will certify SnapDNA products for use by all government agencies and food inspection services. This certification is rare and highly advantageous. Food companies prefer to use the same test as regulators and inspectors.

SnapDNA has been selected by the most the most influential FoodTech accelerators.

 

Customers


Paid Pilots with Fortune 50 and Global 100 companies

SnapDNA has paid pilots with the world’s largest food companies, Nestle and PepsiCo. We are working closely with corporate R&D and global innovation teams as well as key decision makers in food safety and quality towards company-wide roll out because we solve business-critical problems.

SnapDNA has commitments from industry opinion shapers and category leaders in our targeted launch markets; Leafy greens/Produce and Poultry.

Business model


Revenue from each test performed

SnapDNA's business model is to sell single-use cartridges for each test performed at prices competitive with lab testing and provide analysis systems for a recurring monthly fee.

SnapDNA has personal, executive-level relationships with the 16 food companies we are initially targeting. These companies, along with Nestlé and PepsiCo operate over 1000 facilities. SnapDNA projects profitability with systems at just 70 facilities, which we expect to surpass in 2022. In addition, we plan to continually expand our menu of cartridges to detect E. coli, Salmonella and other pathogens.

Market


Food safety testing is an existing $10B market

SnapDNA is addressing a major need in an established, recession-proof, $10 Billion market - Growing to $13 Billion in 3 years.

With SnapDNA, test results are available when the product is ready to ship. We can save a food company millions of dollars a year in storage cost alone. When contamination occurs, we dramatically reduce the risk and financial exposure from outbreaks and of recalls.


Competition


We listened and we delivered

SnapDNA has worked with food companies and solved one of the industry’s biggest technical challenges - on-site, rapid pathogen analysis that meets every requirement to replace lab testing. We know of nothing that comes close. SnapDNA detects only live cells from large, complex industry samples and, unlike lab testing, it can measure the number of pathogen cells in each sample - critical information when trying to determine the cause of a contamination. While the existence proof of SnapDNA could spark new competition, we have a formidable IP barrier including patent applications on fundamental inventions and dozens of trade secret processes.

Vision and strategy


Next generation food testing

SnapDNA enables safer and fresher food while reducing cost and risk for food companies. We enable rapid identification and isolation of pathogens before a contamination can become an outbreak. We are incorporating metadata-rich, cloud-based data and predictive analytics to prevent contaminations across the industry. We allow real-time monitoring of pathogen testing for a food company across all of its facilities, delivering the information every food safety professional requires and every food company needs. We have the vision, technology, and products to capitalize on the inevitable change to rapid analysis in the existing, recession-proof, $10B food pathogen testing market.

We invite you to join us.

Funding


Successfully raised $3M+ in seed rounds

SnapDNA has raised over $3M in prior rounds of seed funding.

SnapDNA founders have personally contributed significantly while investing 8 years developing dozens of fundamental technologies required for our success. Our seed investors include thought leaders and key executives instrumental in the success of some of the Silicon Valley’s most successful companies including Intel, Apple and Genentech. With our commercial product designed and the company poised for a 2021 launch, SnapDNA is doing its first, and likely last, crowdfunding round with this Republic offering to enable others to participate in our upcoming success.

Founders


SnapDNA has the leadership to execute our vision

David Medin has 30 years of executive and C-level experience. He’s opened opportunities in emerging multi-billion-dollar businesses and has successfully led large global product development teams.

Tom Jacobs has 25 years of sales leadership at food processors including 12 years at Tyson Foods. He’s responsible for over $500M in industry sales.

Veronica De Guzman, Ph. D. is a molecular biologist with 20 years of expertise developing high-sensitivity DNA analysis including a fundamental invention that is used by a $2 billion-dollar DNA sequencing company.

Gabriel Matus has 18 years of process engineering experience. His designs are used in $11B of semiconductor manufacturing equipment.

Deal terms


Valuation cap

$28,000,000

The maximum valuation at which your investment converts into equity shares or cash.
Learn more

Discount

10%

If a trigger event for SnapDNA occurs, the discount provision gives investors equity shares (or equal value in cash) at a reduced price.
Learn more.

Minimum investment

$150

The smallest investment amount that SnapDNA is accepting.
Learn more

Funding goal

$1.07M

The maximum amount the offering can raise is $1.07M.
Learn more

Deadline
SnapDNA needs to reach their minimum funding goal before the deadline ( ). If they don’t, all investments will be refunded.
Learn more
Type of security

Crowd SAFE

A SAFE allows an investor to make a cash investment in a company, with rights to receive certain company stock at a later date, in connection with a specific event. · Learn more

How it works

Documents

Republic (OpenDeal Portal LLC, CRD #283874) is hosting this Reg CF securities offering by Bio-NEMS Corporation. View the official SEC filing and all updates:
Official SEC Logo Form C SEC.gov
Company documents
SnapDNA Crowd SAFE SnapDNA Form C.pdf

Bonus perks

In addition to your Crowd SAFE, you'll receive perks for investing in SnapDNA.
Invest
$250
Receive
  • Recognition as an early investor from the SnapDNA leadership team
Invest
$1,000
Receive
  • Recognition as an early investor from the SnapDNA leadership team
  • Invitation to join a group video presentation by the SnapDNA team
Invest
$2,500
Receive
  • Recognition as an early investor from the SnapDNA leadership team
  • Invitation to join a group video with the SnapDNA team
  • Annual investor update
Invest
$5,000
Receive
  • Personalized recognition as an early investor signed by the SnapDNA leadership team
  • 1:1 video conversation with SnapDNA's CEO
  • Annual investor update
Invest
$10,000
Receive
  • Personalized recognition as an early investor signed by the SnapDNA leadership team
  • 1:1 video conversation with SnapDNA's CEO
  • Live "Zoom" tour of SnapDNA's testing system in operation
  • Investor updates
Invest
$25,000
Receive
  • Personalized recognition as an early investor signed by the SnapDNA leadership team
  • 1:1 video conversation with SnapDNA's CEO
  • Live "Zoom" tour of SnapDNA's testing system in operation
  • Investor updates
  • 1st production run SnapDNA test cartridge, numbered and signed by the SnapDNA leadership team

About SnapDNA

Legal Name
Bio-NEMS Corporation
Founded
Apr 2011
Form
Delaware Corporation
Employees
3
Website
snapdna.com
Social Media
Headquarters
Google Map location of of SnapDNA
897 Independence Ave #2C , Mountain View, CA
Headquarters
897 Independence Ave, #2C, Mountain View, CA, United States 94043

SnapDNA Team
Everyone helping build SnapDNA, not limited to employees

Profile picture of David Medin
David Medin
Founder & CEO
Profile picture of Tom Jacobs
Tom Jacobs
Founder
Profile picture of Veronica De Guzman
Veronica De Guzman
Founder
Profile picture of Zeal Panchal
Zeal Panchal
Scientist
1 more team member
David Medin
Founder & CEO
Tom Jacobs
Founder
Veronica De Guzman
Founder
Zeal Panchal
Scientist
Logo of SnapDNA

SnapDNA

SnapDNA successfully raised $1,070,000 from 1774 investors on April 28, 2021
Profile picture of Steve Peklenk
Profile picture of William Walters
Profile picture of Brian Belley
Profile picture of Abdul J Choudhury
Profile picture of Monique Jn-Marie
Steve, William, Brian, Abdul J, Monique, and 1769 others invested. 274 Reviews
Republic

Giving everyone access to early-stage startup investing

For investors
  • Why invest
  • How it works
  • FAQ
  • Risks
  • Privacy policy
  • Accessibility
  • Cookie Preferences
  • Form CRS
For startups
  • Why raise
  • Learn
  • FAQ
  • Tokenized assets
Company
  • About
  • Insights
  • Events
  • Contact
  • Security
  • We're hiring!
Dollar Refer a startup, get $2,500
Dollar Refer a startup, get $2,500

Invest in the app

Android app iOS app

Invest in the app

Android app iOS app

This site (the "Site") is owned and maintained by OpenDeal Inc., which is not a registered broker-dealer. OpenDeal Inc. does not give investment advice, endorsement, analysis or recommendations with respect to any securities. All securities listed here are being offered by, and all information included on this Site is the responsibility of, the applicable issuer of such securities. The intermediary facilitating the offering will be identified in such offering’s documentation.

All related securities activity is conducted by OpenDeal Broker LLC a registered broker-dealer, Member of FINRA and SiPC, an affiliate of OpenDeal Inc. and OpenDeal Portal LLC, located at 149 5th Avenue, 10th Floor, New York, NY 10010. Please check our background on FINRA’s BrokerCheck.

Certain pages discussing the mechanics and providing educational materials regarding regulation crowdfunding offerings may refer to OpenDeal Broker LLC and OpenDeal Portal LLC collectively as “Republic”, solely for explanatory purposes.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC make investment recommendations and no communication, through this Site, or in any other medium, should be construed as a recommendation for any security offered on or off this investment platform. Investment opportunities posted on this Site are private placements of securities that are not publicly traded, involve a high degree of risk, may lose value including the total loss of invested capital, are subject to holding period requirements and are intended for investors who do not need a liquid investment. Past performance is not indicative of future results. Investors must be able to afford the loss of their entire investment. Only qualified investors, who understand the risks of early-stage investment and who meet the Republic's investment criteria may invest. Investors may be restricted to only Accredited Investors or non-U.S. persons, to invest in offerings hosted by OpenDeal Broker. Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC, nor any of their officers, directors, agents and employees make any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy or completeness of any information on this Site or the use of information on this site. Offers to sell securities can only be made through official offering documents that contain important information about the investment and the issuers, including risks. Investors should carefully read the offering documents. Investors should conduct their own due diligence and are encouraged to consult with their tax, legal and financial advisors.

By accessing the Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy. Please also see OpenDeal Broker’s Business Continuity Plan and Additional Risk Disclosures. All issuers offering securities under regulation crowdfunding as hosted by OpenDeal Portal LLC are listed on the All Companies Page. The inclusion or exclusion of an issuer on the Platform Page and/or Republic’s Homepage, which includes offerings conducted under regulation crowdfunding as well as other exemptions from registration, is not based upon any endorsement or recommendation by OpenDeal Inc, OpenDeal Portal LLC, or OpenDeal Broker LLC, nor any of their affiliates, officers, directors, agents, and employees. Rather, issuers of securities may, in their sole discretion, opt-out of being listed on the Platform Page and Homepage.

Investors should verify any issuer information they consider important before making an investment.

Investments in private companies are particularly risky and may result in total loss of invested capital. Past performance of a security or a company does not guarantee future results or returns. Only investors who understand the risks of early stage investment and who meet the Republic's investment criteria may invest.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC verify information provided by companies on this Site and makes no assurance as to the completeness or accuracy of any such information. Additional information about companies fundraising on the Site can be found by searching the EDGAR database, or the offering documentation located on the Site when the offering does not require an EDGAR filing.

To help the government fight the funding of terrorism and money laundering activities, Federal law requires all financial institutions to obtain, verify, and record information that identifies each person who opens an account. Therefore, when you use the Services we will ask for your name, address, date of birth, and other information that will allow us to identify you. We may also ask to see your driver's license, passport or other identifying documents.

Republic and its affiliates are not and do not operate or act as a bank. Certain banking services are provided by BitGo Trust Company, a South Dakota-chartered trust company and registered money services business. BitGo Trust Company is not an FDIC member. Digital (crypto) assets and investment products are not insured by the FDIC, may lose value, and are not deposits or other obligations of BitGo Trust Company and are not guaranteed by BitGo Trust Company. Terms and conditions apply.

Invest in startups using your credit card
You can invest using your credit card

Made in SF/NYC